Zimmer Biomet Holdings Equity 2024

Zimmer Biomet Holdings Equity

12.48 B USD

Zimmer Biomet Holdings Dividend yield

0.8 %

Ticker

ZBH

ISIN

US98956P1021

WKN

753718

In 2024, Zimmer Biomet Holdings's equity was 12.48 B USD, a 3.83% increase from the 12.02 B USD equity in the previous year.

Zimmer Biomet Holdings Aktienanalyse

What does Zimmer Biomet Holdings do?

Zimmer Biomet Holdings Inc is a global company in the medical technology industry that provides innovative products and solutions for orthopedic, dental, and surgical applications. The company was formed through the merger of Zimmer Holdings Inc and Biomet Inc in 2015 and is headquartered in Indiana, USA. The history of Zimmer Biomet Holdings dates back to 1927 when Justin Zimmer founded Zimmer Manufacturing Company, which specialized in the production of orthopedic instruments and prostheses. In 1939, the company introduced the first modular hip endoprosthesis and over the years established itself as a leading provider of orthopedic implants and instruments. Biomet Inc was founded in 1977 with the goal of developing groundbreaking solutions for orthopedic implants. Both companies grew rapidly through acquisitions, strategic partnerships, and innovations before eventually merging. The business model of Zimmer Biomet Holdings focuses on supporting patients and medical professionals in improving quality of life and health. The company offers a wide range of products and services tailored to the needs of patients and medical professionals. These range from joint implants, spine, and knee instruments to digital solutions and patient care services. The company operates in various divisions specializing in different areas of medical technology. The Joint Reconstruction division offers a comprehensive range of implants for hips, knees, shoulders, and elbows, as well as instruments required for orthopedic and surgical procedures. The Surgical division provides products and solutions for surgical procedures, including spine, sports, and trauma surgery. Dental supplies products for dentistry, including implants, instruments, and digital solutions. Additionally, there is the Craniomaxillofacial and Thoracic Surgery division, which focuses on providing care for patients with bone and soft tissue tumors, as well as facial trauma reconstruction. Zimmer Biomet Holdings products are distributed in over 100 countries worldwide and are recognized by medical professionals and patients alike. Some of the most well-known products include the NexGen hip and knee prostheses, Trabecular Metal implants, and digital solutions for patient care such as the Zimmer Biomet mymobility service. In addition to its products and services, Zimmer Biomet Holdings pursues a variety of initiatives and partnerships to improve healthcare and patient outcomes. This includes research projects in collaboration with universities, research institutions, and medical societies, as well as the exchange of best practices among medical professionals. Overall, Zimmer Biomet Holdings has established itself as a leading provider of innovative products and solutions for orthopedic, dental, and surgical applications. With its comprehensive range of products and services and global presence, the company sets standards for healthcare and patient care. Zimmer Biomet Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Zimmer Biomet Holdings's Equity

Zimmer Biomet Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Zimmer Biomet Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Zimmer Biomet Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Zimmer Biomet Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Zimmer Biomet Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Zimmer Biomet Holdings Stock

What is the equity of Zimmer Biomet Holdings this year?

Zimmer Biomet Holdings has equity of 12.48 B USD this year.

What was the equity of Zimmer Biomet Holdings compared to the previous year?

The equity of Zimmer Biomet Holdings has increased/decreased by 3.83% increased compared to the previous year.

What impact does a high equity have on investors of Zimmer Biomet Holdings?

A high equity is advantageous for investors of Zimmer Biomet Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Zimmer Biomet Holdings?

A low equity can be a risk for investors of Zimmer Biomet Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Zimmer Biomet Holdings affect the company?

An increase in equity of Zimmer Biomet Holdings can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Zimmer Biomet Holdings affect the company?

A reduction in equity of Zimmer Biomet Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Zimmer Biomet Holdings?

Some factors that can affect the equity of Zimmer Biomet Holdings include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Zimmer Biomet Holdings so important for investors?

The equity of Zimmer Biomet Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Zimmer Biomet Holdings take to change the equity?

To change equity, Zimmer Biomet Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Zimmer Biomet Holdings pay?

Over the past 12 months, Zimmer Biomet Holdings paid a dividend of 0.96 USD . This corresponds to a dividend yield of about 0.8 %. For the coming 12 months, Zimmer Biomet Holdings is expected to pay a dividend of 0.97 USD.

What is the dividend yield of Zimmer Biomet Holdings?

The current dividend yield of Zimmer Biomet Holdings is 0.8 %.

When does Zimmer Biomet Holdings pay dividends?

Zimmer Biomet Holdings pays a quarterly dividend. This is distributed in the months of October, January, April, July.

How secure is the dividend of Zimmer Biomet Holdings?

Zimmer Biomet Holdings paid dividends every year for the past 17 years.

What is the dividend of Zimmer Biomet Holdings?

For the upcoming 12 months, dividends amounting to 0.97 USD are expected. This corresponds to a dividend yield of 0.8 %.

In which sector is Zimmer Biomet Holdings located?

Zimmer Biomet Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Zimmer Biomet Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zimmer Biomet Holdings from 7/31/2024 amounting to 0.24 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Zimmer Biomet Holdings pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Zimmer Biomet Holdings in the year 2023?

In the year 2023, Zimmer Biomet Holdings distributed 0.96 USD as dividends.

In which currency does Zimmer Biomet Holdings pay out the dividend?

The dividends of Zimmer Biomet Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Zimmer Biomet Holdings stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Zimmer Biomet Holdings

Our stock analysis for Zimmer Biomet Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zimmer Biomet Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.